Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Reduction of prostate-specific antigen after tamsulosin treatment in patients with elevated prostate-specific antigen and lower urinary tract symptoms associated with low incidence of prostate cancer at biopsy.

Tubaro A, De Nunzio C, Mariani S, Trucchi A, Miano R, Vicentini C, Miano L.

Urology. 2010 Aug;76(2):436-41. doi: 10.1016/j.urology.2009.12.083. Epub 2010 Jun 9.

PMID:
20538320
3.
4.

Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.

Roehrborn CG, Kaplan SA, Kraus SR, Wang JT, Bavendam T, Guan Z.

Urology. 2008 Nov;72(5):1061-7; discussion 1067. doi: 10.1016/j.urology.2008.06.067. Epub 2008 Sep 25.

PMID:
18817961
5.

Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels.

Schmid HP, Ravery V, Billebaud T, Toublanc M, Boccon-Gibod LA, Hermieu JF, Delmas V, Boccon-Gibod L.

Urology. 1996 May;47(5):699-703.

PMID:
8650868
6.

The role of free prostate-specific antigen in the diagnosis of prostate cancer.

Akdas A, Cevik I, Tarcan T, Turkeri L, Dalaman G, Emerk K.

Br J Urol. 1997 Jun;79(6):920-3.

PMID:
9202560
7.
8.

Prostate-specific antigen density: correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis.

van Iersel MP, Witjes WP, de la Rosette JJ, Oosterhof GO.

Br J Urol. 1995 Jul;76(1):47-53.

PMID:
7544204
11.
12.

Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.

Hammarsten J, Högstedt B.

Scand J Urol Nephrol. 2002;36(5):330-8.

PMID:
12487736
14.

Prospective study of the role of transurethral resection of the prostate in patients with an elevated prostate-specific antigen level, minor lower urinary tract symptoms, and proven bladder outlet obstruction.

van Renterghem K, Van Koeveringe G, Achten R, van Kerrebroeck P.

Eur Urol. 2008 Dec;54(6):1385-92. doi: 10.1016/j.eururo.2008.06.069. Epub 2008 Jun 26.

PMID:
18599187
15.
16.
19.

Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL.

Babaian RJ, Fritsche H, Ayala A, Bhadkamkar V, Johnston DA, Naccarato W, Zhang Z.

Urology. 2000 Dec 20;56(6):1000-6.

PMID:
11113747
20.

Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients.

Zigeuner RE, Lipsky K, Riedler I, Auprich M, Schips L, Salfellner M, Pummer K, Hubmer G.

Urology. 2003 Sep;62(3):451-5.

PMID:
12946745

Supplemental Content

Support Center